@article{ea260b7756774fa6b59de3d20b0f362c,
title = "The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people",
keywords = "Elderly, Frailty, Hospitalization, Influenza, Vaccine effectiveness",
author = "Andrew, {Melissa K.} and Lingyun Ye and Todd Hatchette and May Elsherif and Scott Halperin and Joanne Langley and Jason Leblanc and McNeil, {Shelly A.}",
note = "Funding Information: Financial support. This work was supported by GlaxoSmithKline Biologicals SA and the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN). Potential conflicts of interest. M. K. A. reports grant funding from GSK, Pfizer, and Sanofi Pasteur. V. S. was employed by GSK Vaccines at the time of the study and is now employed by Novavax Vaccines, and holds shares in the GSK group of companies. T. H. reports payments from the GSK group of companies, Pfizer, and AbbVie. F. H. is employed by the GSK group of companies. G. D. S. was external consultant at Business and Decision Life Sciences (on behalf of GSK) at the time of the study, and is currently employed by the GSK group of companies and holds shares in the GSK group of companies. J. E. M. reports payments to her institution from the GSK group of companies and Sanofi Pasteur. A. C. reports payments from Sanofi. M. E. reports payments from the GSK group of companies, Public Health Agency of Canada, and Canadian Institutes of Health Research (CIHR). S. H. reports payments from the GSK group of companies. B. I. was employed by the GSK group of companies at the time of the study. J. La. reports payments from the GSK group of companies and CIHR. A. M. reports payments to her institution from the GSK group of companies, and payments from Hoffman La Roche and Sanofi Pasteur. J. P. reports payments from the GSK group of companies, Merck, Roche, and Synthetic Biologics. L. V. reports payments from the GSK group of companies. S. A. M. reports payments from the GSK group of companies, Pfizer, Merck, Novartis, and Sanofi. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: cases enrolled by the Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network over the study period. Of the 588 cases enrolled, 528 cases were included in the vaccine effectiveness analysis.",
year = "2017",
month = aug,
day = "1",
doi = "10.1093/infdis/jix282",
language = "English",
volume = "216",
pages = "405--414",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",
}
